A Phase II Study of PX-866 in Patients with Glioblastoma Multiforme at Time of First Relapse or Progression

Trial Profile

A Phase II Study of PX-866 in Patients with Glioblastoma Multiforme at Time of First Relapse or Progression

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Sonolisib (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 07 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 21 May 2013 Results will be presented at the ASCO 2013 meeting, according to the Oncothyreon Q1 2013 financial report.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top